AI clinical decision support for healthcare professionals
“InnovationEditors' PickOpenEvidence Founder Doubles His Wealth As Medical AI Startup Hits $12 Billion ValuationDaniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence is worth $7.6 billion as his AI search tool gains popularity among U.S. doctors. ByRashi Shrivastava,Forbes Staff. Rashi ...”
“Delta: HealthTech InnovatorsHow OpenEvidence Became a $12 Bil...AboutEpisode notesOpenEvidence just hit a $12 billion valuation — here's the full story of how it happened. Daniel Nadler sold his first company, Kensho, to S&P Global for $550 million. Then he turned his attention to one of the most...”
“InnovationEditors' PickOpenEvidence’s Daniel Nadler $1.3 Billion Richer In Just Three Months After The AI Startup Hits $6 Billion ValuationByAmy Feldman,Senior EditorandRashi Shrivastava,Forbes Staff.Follow AuthorsOct 20, 2025, 04:14pm EDTUpdated Oct 20, 2025, 04:15pm…”
“The AI Product Going Viral With Doctors: OpenEvidence, with CEO Daniel NadlerTap to unmute2xThe AI Product Going Viral With Doctors: OpenEvidence, with CEO Daniel NadlerSequoia Capital 17,793 views 1 year agoCopy linkInfoShoppingIf playback doesn't begin shortly, try restarting your…”
“…pharmaceutical ad monetization — appears to have convinced investors that OpenEvidence is on the path to becoming the default platform that doctors go to for medical knowledge. Putting doctors first OpenEvidence CEO Daniel Nadler said his company is unique because it is building its product for ...”